How to Buy Novo Nordisk (Ozempic) Stock
Novo Nordisk A S
Novo Nordisk (Ozempic) is a biotech company located in Denmark, which is part of the Healthcare sector, and is traded under the ticker NVO on the NYSE exchange.
Novo Nordisk (Ozempic) stock last closed at $65.16, up 4.06% from the previous day, and has decreased 48.64% in one year. It has overperformed other stocks in the Biotechnology industry by 0.29 percentage points. Novo Nordisk (Ozempic) stock is currently +14.32% from its 52-week low of $57.00, and -56.02% from its 52-week high of $148.15.
As of Apr 29, 2025, there are 4.47B NVO shares outstanding. The market value of NVO is $290.94B. In the last 24 hours, 10.84M NVO shares were traded.
How to Buy Novo Nordisk (Ozempic) Stock
Not sure how to invest in Novo Nordisk (Ozempic) stock? Here's how.
- Choose where to buy Novo Nordisk (Ozempic) stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Novo Nordisk (Ozempic) stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your method of payment and add your info.
- Analyze Novo Nordisk (Ozempic) stock: The Novo Nordisk (Ozempic) ticker symbol is NVO. Is Novo Nordisk (Ozempic) stock a good investment? Should you buy shares of NVO? How do NVO's underlying business fundamentals look? Do top analysts think Novo Nordisk (Ozempic) is a good buy? Why has NVO's stock price moved recently? (Hint: Our stock analysis website can help you understand if NVO is a good stock to buy).
- Place your NVO trade: Decide if you will purchase NVO shares at the current market price or use a limit order to purchase NVO shares at a specific price.
- Get updates on your NVO position: Create a watchlist to get live updates on your investment in Novo Nordisk (Ozempic) shares.
Step 1: Choose where to buy Novo Nordisk (Ozempic) stock
You will need a brokerage account in order to access the NYSE market and buy NVO stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to invest in NVO stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create a new trading account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've opened your account on mobile trading apps, you can securely and quickly fund your account:
Watch the walkthrough below if you need help transferring funds into your new brokerage account.
Step 4: Analyze Novo Nordisk (Ozempic) stock
After you have decided on the best place to buy Novo Nordisk (Ozempic) stock, it's absolutely critical to research their stock prior to investing, so you truly wrap your head around the risk and upside.
Overview of key NVO info
Novo Nordisk (Ozempic) Due Diligence Score
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on NVO's stock page.
How is NVO stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NVO's fair value.
Using relative valuations measures:
- NVO may be undervalued based on its P/E ratio of 20.58x, relative to Biotechnology industry P/E ratio of -158.75x
- NVO could be overvalued based on its P/B ratio of 14.52x, relative to Biotechnology industry P/B ratio of 4.37x
- NVO may be overvalued based on its PEG ratio of 1.09x
You can access additional valuation analysis on NVO's stock here.
NVO Financial Health Summary
Pros:
- There are more short-term assets than long-term liabilities on the NVO balance sheet.
- NVO earnings of $17.76B is not sufficient to cover its interest payments.
- NVO's operating cash flow of $16.89B allows it to safely service it's debt of $14.36B.
Cons:
- NVO profit margin has gone down from 36% to 34.8% in the past year.
- There are more short-term liabilities than short-term assets on the NVO balance sheet.
- Total NVO debt is higher than 5 years ago, relative to shareholder equity.
- NVO has a relatively high debt to equity ratio of 2.25.
Do Wall Street analysts think it's a good time to buy Novo Nordisk (Ozempic) stock
Out of 2 Equities analysts who give ratings on NVO, the consensus analyst rating on Novo Nordisk (Ozempic) is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Novo Nordisk (Ozempic) stock forecast page.
Metrics for Advanced NVO Traders
NVO Revenue
Last year, NVO earnings were $14.10B. Over the last five year, NVO's earnings have increased by 20.88% per year. This was faster than the Biotechnology industry average of 10.52%.
Last year, NVO revenue was $40.56B. Over the last five year, NVO's revenue has grown by 17.33% per year. This was slower than the Biotechnology industry average of 45.47%.
You can analyze NVO's earnings and revenue performance here.
Are NVO executives and large shareholders buying or selling the stock?
Over the last year, insiders at NVO have not bought or sold any shares.
Dig into more about who owns NVO shares here.
Does NVO stock generate passive income?
Novo Nordisk (Ozempic) pays a dividend of 2.47%, compared to the Biotechnology industry's average dividend yield of 1.9%. If you owned $1,000 worth of NVO stock, you would have received $24.74 in the past year.
Novo Nordisk (Ozempic) dividend payments have consistently grown over the past decade but have not remained stable.
Dig into more info about Novo Nordisk (Ozempic) dividend yield and history here.
NVO Social Trading Data
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your NVO trade
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at an exact price, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you require additional assistance investing in stocks on eToro, click the helpful video below:
Step 6: Get updates on your NVO position
Now that you own some NVO stock, you'll want to keep up with your new investment.
Make a watchlist to track your NVO stock.
NVO Feed
How to Buy Stock in Novo Nordisk (Ozempic)
To summarize, here are the 6 steps to buy Novo Nordisk (Ozempic) stock:
- Choose where to buy Novo Nordisk (Ozempic) stock
- Create your brokerage account
- Deposit money your brokerage account
- Analyze Novo Nordisk (Ozempic) stock
- Place your NVO trade
- Get updates on your NVO position
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep track of your investment in Novo Nordisk (Ozempic), create your watchlist below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.